EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
Angelini Ventures has already invested €125 million in 22 startups
Angelini Ventures has already invested €125 million in 22 startups
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
India currently hosts more than 10,075 biotech startups
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Subscribe To Our Newsletter & Stay Updated